Back to PEA (Phenylethylamine)

Timing & pharmacokinetics

How long does PEA (Phenylethylamine) take to work?

Onset timing for PEA (Phenylethylamine) varies in the clinical literature. Onset timing is not well-quantified in our dataset, refer to clinical citations on the main entry.

Onset

Half-life

0.2h

Duration

Timing

AM/pre-task

Key facts

typical dose
100–500 mg
dose frequency
as needed
timing
AM/pre-task
with food
optional
half-life
0.2 hours
safety score
3/5
evidence grade
C
class
amino-acid
PubMed citations
1100
legal status (US)
Over-the-counter
legal status (UK)
Over-the-counter
legal status (EU)
Over-the-counter
legal status (AU)
Over-the-counter
primary mechanism
Releases dopamine and norepinephrine from presynaptic vesicles.

Onset window

PEA (Phenylethylamine) onset times in the published literature vary widely. Refer to the citations on the main PEA (Phenylethylamine) entry for compound-specific pharmacokinetic data.

Food effect: Food has only modest effect on PEA (Phenylethylamine) onset. Take with or without food depending on GI tolerance.

Half-life and dosing frequency

Very short 0.2-hour half-life, fast clearance, can be dosed multiple times per day if needed.

Acute vs. chronic effect

Some nootropics work the first time you take them (PEA (Phenylethylamine) may or may not). Others, adaptogens, racetams, and most botanicals targeting BDNF or NGF pathways, require 2–4 weeks of daily dosing before the full effect emerges.

If you don’t feel anything after a single dose and the compound is in the chronic-effect category, that is normal, extend the trial to 2–4 weeks before evaluating. If it is in the acute category and you feel nothing, consider dose, vendor sourcing, or whether the compound matches your goal.

Protocol note from the PEA (Phenylethylamine) entry

Avoid with MAOIs. Pair with hordenine to extend duration.

Mechanism, safety, and citations for PEA (Phenylethylamine) are on the main reference page, see PEA (Phenylethylamine). For full dose protocol see PEA (Phenylethylamine) dosage. To check for stack-level pharmacokinetic conflicts, use the interaction checker.

Onset and pharmacokinetic data reflect the published literature for healthy adults at typical doses. Individual variation in absorption, metabolism (CYP genotype), and gut transit can shift onset by ±50%. This page is informational and not medical advice. See our full disclaimer.